Cargando…

Mitochondrial Dysfunction as a Therapeutic Target in COPD

Detalles Bibliográficos
Autor principal: CHUNG, Kian Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Research Institute of Tuberculosis and Lung Disease 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684722/
https://www.ncbi.nlm.nih.gov/pubmed/29158756
_version_ 1783278535244251136
author CHUNG, Kian Fan
author_facet CHUNG, Kian Fan
author_sort CHUNG, Kian Fan
collection PubMed
description
format Online
Article
Text
id pubmed-5684722
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher National Research Institute of Tuberculosis and Lung Disease
record_format MEDLINE/PubMed
spelling pubmed-56847222017-11-20 Mitochondrial Dysfunction as a Therapeutic Target in COPD CHUNG, Kian Fan Tanaffos Supplement National Research Institute of Tuberculosis and Lung Disease 2017 /pmc/articles/PMC5684722/ /pubmed/29158756 Text en Copyright© 2017 National Research Institute of Tuberculosis and Lung Disease http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement
CHUNG, Kian Fan
Mitochondrial Dysfunction as a Therapeutic Target in COPD
title Mitochondrial Dysfunction as a Therapeutic Target in COPD
title_full Mitochondrial Dysfunction as a Therapeutic Target in COPD
title_fullStr Mitochondrial Dysfunction as a Therapeutic Target in COPD
title_full_unstemmed Mitochondrial Dysfunction as a Therapeutic Target in COPD
title_short Mitochondrial Dysfunction as a Therapeutic Target in COPD
title_sort mitochondrial dysfunction as a therapeutic target in copd
topic Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684722/
https://www.ncbi.nlm.nih.gov/pubmed/29158756
work_keys_str_mv AT chungkianfan mitochondrialdysfunctionasatherapeutictargetincopd